PROTAGENIC THERAPEUTICS INC's ticker is PTIXW and the CUSIP is 74365N111. A total of 2 filers reported holding PROTAGENIC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,316 | -10.4% | 177,196 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $5,936 | +38.4% | 177,196 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $4,288 | -41.0% | 177,196 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $7,265 | -39.5% | 177,196 | -37.9% | 0.00% | -50.0% |
| Q3 2022 | $12,000 | -75.5% | 285,497 | -13.0% | 0.00% | -81.8% |
| Q2 2022 | $49,000 | -68.6% | 328,223 | -54.7% | 0.01% | +1000.0% |
| Q1 2022 | $156,000 | +126.1% | 724,132 | +298.9% | 0.00% | -92.3% |
| Q4 2021 | $69,000 | -51.7% | 181,534 | -50.2% | 0.01% | -43.5% |
| Q3 2021 | $143,000 | -45.0% | 364,791 | -0.3% | 0.02% | -54.0% |
| Q2 2021 | $260,000 | – | 365,790 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Warberg Asset Management LLC | 364,791 | $143,000 | 0.02% |
| UBS Group AG | 600 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |